Impede Embolization Plug
Payments companies reported to CMS as associated with Impede Embolization Plug. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Impede Embolization Plug, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Impede Embolization Plug
These are the largest totals companies reported as associated with Impede Embolization Plug. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Dai Yamanouchi | Madison, WI | Vascular Surgery | $20,148.40 |
| Thomas O'Donnell | New York, NY | Vascular Surgery | $13,323.73 |
| Virendra Patel | New York, NY | Vascular Surgery | $12,045.99 |
| Marc Schermerhorn | Boston, MA | Vascular Surgery | $7,355.22 |
| Thomas Maldonado | New York, NY | Vascular Surgery | $5,153.09 |
| John Kedora | Dallas, TX | Vascular Surgery | $3,785.50 |
| Anand Dayama | Sioux Falls, SD | Vascular Surgery | $2,624.09 |
| Dipankar Mukherjee | Falls Church, VA | Vascular Surgery | $2,551.78 |
| Timur Sarac | Jacksonville, FL | Vascular Surgery | $2,188.36 |
| Edvard Skripochnik | Bronx, NY | Vascular Surgery | $1,901.74 |
Prescribed Impede Embolization Plug?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.